End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
183.5 TWD | -7.56% | -2.65% | +168.67% |
05-14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
05-14 | Lumosa Therapeutics Co., Ltd. Announces the Change in Juristic-Person Director Representative | CI |
Sales 2024 * | 57M 1.78M 2.42M | Sales 2025 * | 1.57B 48.93M 66.58M | Capitalization | 30.27B 944M 1.28B |
---|---|---|---|---|---|
Net income 2024 * | -401M -12.5M -17.01M | Net income 2025 * | 786M 24.5M 33.33M | EV / Sales 2024 * | 527 x |
Net cash position 2024 * | 259M 8.07M 10.98M | Net cash position 2025 * | 954M 29.73M 40.46M | EV / Sales 2025 * | 18.7 x |
P/E ratio 2024 * |
-75.5
x | P/E ratio 2025 * |
38.6
x | Employees | 47 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.33% |
1 day | -7.56% | ||
1 week | -2.65% | ||
Current month | +6.69% | ||
1 month | -3.93% | ||
3 months | +15.77% | ||
6 months | +207.37% | ||
Current year | +168.67% |
Managers | Title | Age | Since |
---|---|---|---|
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 11-09-15 |
Chia Chi Yang
DFI | Director of Finance/CFO | - | 22-01-31 |
June Kuo
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wan Lai Cheng
BRD | Director/Board Member | - | 14-07-24 |
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 11-09-15 |
I Hsiung Chang
BRD | Director/Board Member | - | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 183.5 | -7.56% | 2,294,051 |
24-05-14 | 198.5 | +4.47% | 1,448,689 |
24-05-13 | 190 | +0.26% | 555,255 |
24-05-10 | 189.5 | +3.84% | 719,437 |
24-05-09 | 182.5 | -3.18% | 548,794 |
End-of-day quote Taipei Exchange, May 14, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.67% | 942M | |
+7.52% | 113B | |
+11.38% | 106B | |
+0.82% | 22.27B | |
-12.64% | 22.22B | |
-4.50% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- 6535 Stock